Our licensing opportunities
Discover our wide variety of oncology-focused projects available for licensing or collaboration.
These include novel biological and chemotherapeutic agents, diagnostics and enabling technologies, as well as data and medtech.
From early stage discovery through to clinical trials and beyond
Our pipeline
We've played an instrumental role in bringing 13 new cancer drugs to market. Now, we're continuing to fast-track scientific breakthroughs into patient benefit through our pioneering research.
Want to find out more?
Our team of experts can help you explore our licensing and collaboration opportunities.